BBC News  1 hr ago  Comment 
Consolidation continues in the pharmaceutical industry as both Abbott Laboratories and Sanofi announce multibillion dollar expansion efforts.
Clusterstock  6 hrs ago  Comment 
The French pharmaceuticals giant Sanofi has made a near-$10-billion (£6.85 billion) bid for the American biotech firm Medivation, which specialises in cancer treatments. In a letter sent to Medivation on Thursday, Sanofi's chief executive,...
New York Times  6 hrs ago  Comment 
Sanofi said that it first privately made an offer to acquire the prostate cancer drug maker nearly two weeks ago but had not received a response to its offer.
The Economic Times  Apr 27  Comment 
The company has called an annual general meeting on Friday when it will seek approval from the shareholder to appoint these three directors.
Benzinga  Apr 21  Comment 
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) today announced positive data from preclinical studies evaluating MM-310, an antibody directed nanotherapeutic (ADN) that encapsulates a newly engineered form of the highly potent chemotherapy...
Benzinga  Apr 19  Comment 
Sanofi (NYSE: SNY) today announced a €300 million investment to expand its site in Geel, Belgium. The investment furthers Sanofi's commitment to driving the future of biologics by expanding manufacturing and commercial capabilities in order to...
Wall Street Journal  Apr 19  Comment 
Wall Street Journal  Apr 15  Comment 
French drugmaker Sanofi said an expert panel of the World Health Organization had recommended the use of its dengue vaccine in countries where the mosquito-borne disease is widespread, paving the way for vaccination campaigns in Asia and Latin...
Motley Fool  Apr 14  Comment 
Both have been disappointing long-term investments, but which of these two healthcare companies should investors favor today?
FiercePharma  Apr 13  Comment 
At the beginning of the month the big question was: who wants to buy the cancer biotech Medivation? Now we have an answer in the form of Sanofi--but things haven't gone well as the drugmaker was firmly rebuffed after making its feelings known.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki